Calculate Your Salary Ranking
Home > Ortho-McNeil Pharmaceutical Salary

Ortho-McNeil Pharmaceutical Salary
  • 45
  • 88
  • 88

Ortho-McNeil Pharmaceutical average salary is $50,000, median salary is $50,000 with a salary range from $50,000 to $50,000.
Ortho-McNeil Pharmaceutical salaries are collected from government agencies and companies. Each salary is associated with a real job position. Ortho-McNeil Pharmaceutical salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 1 Ortho-McNeil Pharmaceutical Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More Info
Sales Representative 50,000-50,000 Columbus, OH, 43085 2010 Ortho-McNeil Pharmaceutical Sales Representative Salaries (1)
Ortho-McNeil Pharmaceutical Columbus, OH Salaries
Ortho-McNeil Pharmaceutical Jobs
See more Ortho-McNe Jobs »
Calculate how much you could earn

It's FREE. Based on your input and our analysis.    How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address
Recent Ortho-McNeil Pharmaceutical Salaries (February 27, 2017)
Assistant Professor University of Oklahoma $42,860 Norman, OK, 73019 01/05/2015
General OMRON $65,998 Houston, TX, 77001 09/07/2015

Ortho-McNeil Pharmaceutical salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Ortho-McNeil Pharmaceutical Information
  • Ortho-McNeil Pharmaceutical Inc
  • Industry: BioTech/Drugs
  • City: Titusville, NJ
  • Although we often talk about our future, we also are proud of our past. Our legacy of providing quality health care products and services spans three centuries.Ortho-McNeil was formed by the 1993 merger of two Johnson & Johnson companies, Ortho Pharmaceutical Corporation and McNeil Pharmaceutical. Prior to the merger, each company had a strong reputation for developing and marketing prescription products in distinct therapeutic classes: Ortho in women¡¯s health, and McNeil in central nervous system and pain treatment.